Showing results 1 - 10 of 14
Whether it is visible or not, chemistry is a driving factor in nearly every field of industry – not least pharmaceuticals. As both qualified scientists and highly experienced patent attorn...
On Wednesday 5th June, Gill Jennings & Every hosted an event to investigate how Artificial Intelligence (AI) and Machine Learning (ML) are transforming digital healthcare and pharmaceuticals. &nbs...
It brings us great pride to announce that GJE has been listed first place on the Financial Times leader board of top firms in the “Europe’s Leading Patent Law Firms 2023” annual awards. GJ...
We are pleased to be recognised in the 2023 Chambers and Partners guide. Chambers and Partners identifies the best law firms globally through interviews and client feedback. The directory assess...
The development of drugs can be a slow process due to the need for safety and extensive testing. Before a drug can proceed to human trials, it is important to ascertain information relating to efficac...
For a fourth consecutive year, GJE has been top-ranked on the Financial Times’ leader board of best firms in “Europe’s Leading Patent Law Firms 2022” annual awards. The firm received five Gold...
We are delighted to announce that Ross Cummings and Ian Jones have joined the Partnership. Ross Cummings joined GJE in 2017, having previously worked at another top tier firm of patent and trade mark ...
We are pleased to be recognised in the 2022 edition of Chambers & Partners. Chambers & Partners identifies the best law firms globally through interviews and client feedback. The d...
GJE has been listed joint first place with two other firms on the Financial Times leader board of top firms in the “Europe’s Leading Patent Law Firms 2021” annual awards. The firm received...
Tuesday 22nd of June, 2021, 2:00pm (London UK – BST) 60 mins What will the talk cover? Inventions dependent on chemistry span many different technology areas – from coatings and polymers...